181 related articles for article (PubMed ID: 29615488)
1. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
Llibre A; Shimakawa Y; Mottez E; Ainsworth S; Buivan TP; Firth R; Harrison E; Rosenberg AR; Meritet JF; Fontanet A; Castan P; Madejón A; Laverick M; Glass A; Viana R; Pol S; McClure CP; Irving WL; Miele G; Albert ML; Duffy D
Gut; 2018 Nov; 67(11):2017-2024. PubMed ID: 29615488
[TBL] [Abstract][Full Text] [Related]
2. The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.
Chevaliez S; Dubernet F; Dauvillier C; Hézode C; Pawlotsky JM
J Clin Virol; 2017 Jun; 91():5-11. PubMed ID: 28380393
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance and Usability of the Genedrive
Lamoury FMJ; Njouom R; Amougou-Atsama M; Yiagnigni Mfopou E; Berishvili N; Sologashvili M; Fajardo E; Malobela A; Macé A; Chirehwa M; Alkhazashvili M; Ivanova Reipold E
Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33921930
[TBL] [Abstract][Full Text] [Related]
4. Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.
Neto MF; Butzler MA; Reed JL; Rui X; Fisher MJ; Kelso DM; McFall SM
J Virol Methods; 2017 Oct; 248():107-115. PubMed ID: 28673855
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of the Aptima
Garbuglia AR; Bibbò A; Sciamanna R; Pisciotta M; Capobianchi MR
J Clin Virol; 2017 Jul; 92():1-6. PubMed ID: 28475925
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance of the VERIS HCV assay for hepatitis C virus RNA quantification.
Izquierdo L; Prégermain C; Hottelet C; Decombe G; Roque-Afonso AM
J Clin Virol; 2017 Aug; 93():1-7. PubMed ID: 28550721
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of the automated COBAS AMPLICOR HCV MONITOR test version 2.0 for quantifying serum hepatitis C virus RNA and comparison to the quantiplex HCV version 2.0 test.
Yu ML; Chuang WL; Dai CY; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY
J Clin Microbiol; 2000 Aug; 38(8):2933-9. PubMed ID: 10921954
[TBL] [Abstract][Full Text] [Related]
8. An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay.
Sarrazin C; Dierynck I; Cloherty G; Ghys A; Janssen K; Luo D; Witek J; Buti M; Picchio G; De Meyer S
J Clin Microbiol; 2015 Apr; 53(4):1264-9. PubMed ID: 25653396
[TBL] [Abstract][Full Text] [Related]
9. Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia.
Thedja MD; Wibowo DP; El-Khobar KE; Ie SI; Turyadi ; Setiawan L; Murti IS; Muljono DH
Am J Trop Med Hyg; 2021 May; 105(1):117-124. PubMed ID: 33999849
[TBL] [Abstract][Full Text] [Related]
10. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.
Vermehren J; Maasoumy B; Maan R; Cloherty G; Berkowski C; Feld JJ; Cornberg M; Pawlotsky JM; Zeuzem S; Manns MP; Sarrazin C; Wedemeyer H
Clin Infect Dis; 2016 May; 62(10):1228-1234. PubMed ID: 26908802
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an RT-qPCR assay for rapid detection and quantification of hepatitis C virus RNA for routine testing in Moroccan clinical specimens.
El Hadi H; Benani A; Qmichou Z; Lazar F; Bakri Y; Ait Benhassou H; Moumen A
J Med Virol; 2019 Mar; 91(3):428-436. PubMed ID: 30267578
[TBL] [Abstract][Full Text] [Related]
12. Rapid point-of-care HCV RNA quantification in capillary whole blood for diagnosing chronic HCV infection, monitoring treatment and detecting reinfection.
Bregenzer A; Warmann N; Ottiger C; Fux CA
Swiss Med Wkly; 2019 Oct; 149():w20137. PubMed ID: 31656039
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and monitoring of HCV infection using the cobas
Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A
J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694
[TBL] [Abstract][Full Text] [Related]
14. Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population.
Naveed A; Khalid A; Janjua N; Cloherty GA; Akhter S
J Viral Hepat; 2024 Jun; 31(6):320-323. PubMed ID: 38483043
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Abbott real-time PCR assay using m2000sp and m2000rt for hepatitis C virus RNA quantification.
Chevaliez S; Bouvier-Alias M; Pawlotsky JM
J Clin Microbiol; 2009 Jun; 47(6):1726-32. PubMed ID: 19369435
[TBL] [Abstract][Full Text] [Related]
16. The new Xpert HCV viral load real-time PCR assay accurately quantifies hepatitis C virus RNA in serum and whole-blood specimens.
Wlassow M; Poiteau L; Roudot-Thoraval F; Rosa I; Soulier A; Hézode C; Ortonne V; Pawlotsky JM; Chevaliez S
J Clin Virol; 2019 Aug; 117():80-84. PubMed ID: 31254912
[TBL] [Abstract][Full Text] [Related]
17. Rapid virological response assessment by Abbott RealTime hepatitis C virus assay for predicting sustained virological responses in patients with hepatitis C virus genotype 1 treated with pegylated-interferon and ribavirin.
Su PY; Yen HH; Hsu YC; Wu SS; Kor CT; Su WW
Kaohsiung J Med Sci; 2016 Jul; 32(7):381-6. PubMed ID: 27450028
[TBL] [Abstract][Full Text] [Related]
18. HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay.
Antonucci F; Cento V; Sorbo MC; Manuelli MC; Lenci I; Sforza D; Di Carlo D; Milana M; Manzia TM; Angelico M; Tisone G; Perno CF; Ceccherini-Silberstein F
J Virol Methods; 2017 Aug; 246():1-7. PubMed ID: 28408312
[TBL] [Abstract][Full Text] [Related]
19. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.
Freiman JM; Wang J; Easterbrook PJ; Horsburgh CR; Marinucci F; White LF; Kamkamidze G; Krajden M; Loarec A; Njouom R; Nguyen KV; Shiha G; Soliman R; Solomon SS; Tsertsvadze T; Denkinger CM; Linas B
J Hepatol; 2019 Jul; 71(1):62-70. PubMed ID: 30797050
[TBL] [Abstract][Full Text] [Related]
20. What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? '
Lemoine M; Tillmann HL
Gut; 2018 Nov; 67(11):1916-1917. PubMed ID: 29959169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
